Company profile: Halo Diagnostics
1.1 - Company Overview
Company description
- Provider of precision diagnostics for early detection, offering HALO PathWayβ’, an improved breast cancer screening approach at the HALO Breast Care Center; AI-powered CT 5100 Incisive for advanced medical imaging; expanded imaging and genetic services in Greater Chico, CA; and the HALO Wayβ’ experience.
Products and services
- HALO Wayβ’: Delivers a clinical-grade precision diagnostics experience enabling early detection of cancer and disease to help save lives
- HALO PathWayβ’: Supplies a screening-optimized, improved breast cancer screening approach offered by the HALO Breast Care Center for earlier detection
- AI-Powered CT 5100 Incisive: Produces a deep-learning-driven CT imaging system utilizing AI for advanced medical imaging, enabling precision diagnostics
Key contacts
π
π
Financial details
π
1.2 - Competitors and similar companies to Halo Diagnostics
Shiel
HQ: United States
Website
- Description: Provider of clinical laboratory operations.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Shiel company profile β
Life Molecular Imaging
HQ: Germany
Website
- Description: Provider of neuroimaging and cardiovascular molecular imaging services and PET tracers. Products include Neuraceq, a radioactive PET agent to estimate beta amyloid neuritic plaque density in adults with cognitive impairment; 18F-PI-2620 to image tau; 18F-florbetaben to detect amyloid deposits (under investigation for cardiac amyloidosis); and 18F-GP1 under investigation to detect acute thromboembolic events.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Life Molecular Imaging company profile β
Cambridge Clinical Laboratories
HQ: United Kingdom
Website
- Description: Provider of oncology, virology, and diagnostics services for the healthcare sector, offering personalized medicine and quality service, and adopting new diagnostic technologies and novel assays to help UK healthcare.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Cambridge Clinical Laboratories company profile β
Edda Technology
HQ: United States
Website
- Description: Provider of computer-assisted 3D medical imaging software and guidance tools, including IQQA-BodyImaging for analysis and visualization of liver, lung, and kidney to support surgical planning and assessment; IQQA-Guide for real-time 3D guidance in abdominal and thoracic procedures; and IQQA-BodyImaging Interventional for precision analytics aiding needle placement for ablation and biopsy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Edda Technology company profile β
Clearbridge BioMedics
HQ: Singapore
Website
- Description: Provider of bleeding edge genetic testing services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Clearbridge BioMedics company profile β
π
2.M&A buyers
2.1 Potential strategic acquirers in the sector
π
π
π
π
View all strategic buyers with complete profiles
Start Free Trial β
2.2 - Strategic buyer groups for Halo Diagnostics
π
Buyer group 1: ββββββββ ββββββββ
ββ companies
Description: ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ
Key Products: ββββββββ, ββββββββ, ββββββββ, ββββββββ
π
View all companies in this group
Request Free Trial Now β
π
Buyer group 2: ββββββββ ββββββββ
ββ companies
Description: ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ
Key Products: ββββββββ, ββββββββ, ββββββββ, ββββββββ
π
View all companies in this group
Request Free Trial Now β
π
Buyer group 3: ββββββββ ββββββββ
ββ companies
Description: ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ
Key Products: ββββββββ, ββββββββ, ββββββββ, ββββββββ
π
View all companies in this group
Request Free Trial Now β
π Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial β
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Halo Diagnostics
2.2 - Growth funds investing in similar companies to Halo Diagnostics
π
View all growth equity funds with complete profiles
Start Free Trial β
4 - Top valuation comps for Halo Diagnostics
4.2 - Public trading comparable groups for Halo Diagnostics
π Unlock all public trading comparable groups with complete valuation data
Start Free Trial β